PER 1.23% 8.0¢ percheron therapeutics limited

UPDATE ON PFIZER’S PHASE 1B OPEN-LABEL MINI-DYSTROPHIN GENE THERAPY TRIAL FOR DUCHENNE, page-19

  1. 3,549 Posts.
    lightbulb Created with Sketch. 771

    Well at the AGM..MD said animals...dystrophin drugs...atl1002 all had been ordered...so I would say at least 6 months before you will hear anything on the results...progress announcement can be expected but nothing in the effects as the trial will run for a few weeks...may be 8-12 weeks...AGM IN Dec...

    All sources available and test can start in March...Hence possible announcement by June...

    FDA update is expected this q on the toxicity and I think it's a big announcement as it will also make fast track possible ..
    I am pretty sure that FDA news will be positive as the toxicity design application would be made in line of the FDA expectations...after all there has already been one f...up ...I am sure won't happen again and any news on this will take the SP over 35c again...also the options will be in play for additional funds once that happens...

    IMO DYOR
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.